Benitec Biopharma

BENITEC BIOPHARMA INC

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Benitec Biopharma Inc

News

Press Releases

Benitec Biopharma to Participate in Upcoming Investor Conferences in December

Health Care

Benitec Biopharma to Participate in Upcoming Conferences in January and February

Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference

Earnings

Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update

Benitec Biopharma to Participate in Upcoming Conferences in March

Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301 in Phase 1b/2a Study to be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering

Benitec Biopharma Releases Third Quarter 2025 Financial Results

Benitec Biopharma Provides Operational Updates

Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update

BNTC

AC Immune

Aldeyra Therapeutics, Inc. - Common Stock

Aldeyra Therapeutics

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics

Altimmune

Amarin Corporation plc - American Depositary Shares

Amarin Corp

Annexon

Aura Biosciences

Candel Therapeutics

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

Cellectis S.A. - American Depositary Shares

Cellectis

DiaMedica Therapeutics Inc. - Common Stock

DiaMedica Therapeutics

Design Therapeutics

Editas Medicine

ETHZilla

Immuneering Corporation - Class A Common Stock

Immuneering

Invivyd

Jade Biosciences

Kamada

Lineage Cell Therapeutics, Inc. Common Stock

Lineage Cell Therapeutics

Larimar Therapeutics, Inc. - Common Stock

Larimar Therapeutics

Lyell Immunopharma

PepGen

Rocket Pharmaceuticals, Inc. - Common Stock

Rocket Pharmaceuticals

Replimune Group

JMP Securities

Oppenheimer

HC Wainwright & Co.

Citizens Capital Markets

Baird

Comments

Benitec Biopharma

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO